UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4676
NewAmsterdam Pharma
NAMS
$3.34B
| $2.06M | ﹤0.01% |
80,210
-50,030
| -38% | -$1.06M |
|
4677
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$159M
| $2.06M | ﹤0.01% |
22,124
-1,245
| -5% | -$119K |
|
4678
State Street SPDR Dow Jones International Real Estate ETF
RWX
$270M
| $2.06M | ﹤0.01% |
89,378
-43,721
| -33% | -$1.09M |
|
|
AVK
4679
Advent Convertible and Income Fund
AVK
$563M
| $2.05M | ﹤0.01% |
174,298
+29,687
| +21% | +$349K |
|
4680
Methanex
MEOH
$4.12B
| $2.05M | ﹤0.01% |
40,976
+15,483
| +61% | +$681K |
|
4681
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$594M
| $2.05M | ﹤0.01% |
14,803
+233
| +2% | +$32.8K |
|
4682
State Street SPDR S&P Pharmaceuticals ETF
XPH
$515M
| $2.05M | ﹤0.01% |
47,576
+7,432
| +19% | +$338K |
|
4683
CALL
Rocket Companies
RKT
$38.9B
| $2.04M | ﹤0.01% |
181,600
| – | – |
|
4684
CALL
Hawaiian Electric Industries
HE
$2.14B
| $2.04M | ﹤0.01% |
210,000
| – | – |
|
4685
Gerdau
GGB
$9.7B
| $2.04M | ﹤0.01% |
708,028
+488,568
| +223% | +$1.61M |
|
4686
Evolv Technologies
EVLV
$1.1B
| $2.03M | ﹤0.01% |
514,584
+418,656
| +436% | +$1.47M |
|
4687
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$774M
| $2.03M | ﹤0.01% |
45,064
-26,371
| -37% | -$1.2M |
|
4688
Inspire Small/Mid Cap Impact ETF
ISMD
$345M
| $2.03M | ﹤0.01% |
54,016
+313
| +0.6% | +$12.1K |
|
4689
Koppers
KOP
$969M
| $2.03M | ﹤0.01% |
62,525
+51,677
| +476% | +$1.85M |
|
4690
Playboy Inc
PLBY
$141M
| $2.02M | ﹤0.01% |
1,386,419
+1,382,636
| +36,549% | +$1.6M |
|
4691
iShares Global Materials ETF
MXI
$362M
| $2.02M | ﹤0.01% |
26,044
-1,394
| -5% | -$120K |
|
4692
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$668M
| $2.02M | ﹤0.01% |
37,048
+6,837
| +23% | +$386K |
|
4693
Enviri
NVRI
$620M
| $2.02M | ﹤0.01% |
261,922
+143,379
| +121% | +$1.2M |
|
4694
Banco Santander Chile
BSAC
$16.6B
| $2.02M | ﹤0.01% |
106,925
+103,054
| +2,662% | +$2.01M |
|
4695
Cerus
CERS
$474M
| $2.02M | ﹤0.01% |
1,309,002
+1,066,666
| +440% | +$1.83M |
|
4696
POSCO
PKX
$17.5B
| $2.01M | ﹤0.01% |
46,465
+11,329
| +32% | +$630K |
|
4697
iShares Global Financials ETF
IXG
$700M
| $2.01M | ﹤0.01% |
20,929
+2,753
| +15% | +$268K |
|
|
KW
4698
DELISTED
Kennedy-Wilson Holdings
KW
| $2.01M | ﹤0.01% |
201,160
+142,946
| +246% | +$1.56M |
|
4699
CALL
FirstEnergy
FE
$27.5B
| $2M | ﹤0.01% |
50,400
| – | – |
|
4700
iShares Core 5-10 Year USD Bond ETF
IMTB
$275M
| $2M | ﹤0.01% |
47,179
-309
| -0.7% | -$13.3K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.